LIVIA GROUP ANNOUNCES THE ACQUISITION OF PRIME EUROPEAN THERAPEUTICALS S.P.A. FROM ALBANY MOLECULAR RESEARCH INC.

LIVIA Corporate Development SE announces the acquisition of Prime European Therapeuticals S.p.A. (“Euticals”), from Albany Molecular Research Inc. (“AMRI”).